217 related articles for article (PubMed ID: 22681714)
1. Disseminated juvenile xanthogranuloma associated with follicular lymphoma in an adult: successful treatment with chemotherapy and rituximab. A review of the literature.
Narváez-Moreno B; Pulpillo-Ruiz Á; De Zulueta-Dorado T; Conejo-Mir J
Actas Dermosifiliogr; 2013 Apr; 104(3):242-6. PubMed ID: 22681714
[TBL] [Abstract][Full Text] [Related]
2. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
[TBL] [Abstract][Full Text] [Related]
3. Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab.
Jensen M; Elter T; Engert A; Reiser M
Onkologie; 2006 Mar; 29(3):90-2. PubMed ID: 16514269
[TBL] [Abstract][Full Text] [Related]
4. [Primary nodal follicular lymphoma with secondary cutaneous manifestations. First-line rituximab monotherapy].
Koch R; Sander CA
Hautarzt; 2010 Nov; 61(11):976-9. PubMed ID: 20221574
[TBL] [Abstract][Full Text] [Related]
5. Optimization of postremission therapy in follicular lymphoma: efficacy of rituximab maintenance.
Roy R; Gordon LI
J Natl Compr Canc Netw; 2011 May; 9(5):563-71. PubMed ID: 21550969
[TBL] [Abstract][Full Text] [Related]
6. Rapid-onset, prolonged bone marrow failure following rituximab therapy of follicular lymphoma.
Debatin L; Schmitt-Graeff A; Veelken H
Onkologie; 2011; 34(6):322-4. PubMed ID: 21625186
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of rituximab in follicular lymphoma.
Johnston KM; Bolbocean C; Connors J; Peacock S
Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):569-77. PubMed ID: 23140274
[TBL] [Abstract][Full Text] [Related]
8. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.
Pettengell R; Schmitz N; Gisselbrecht C; Smith G; Patton WN; Metzner B; Caballero D; Tilly H; Walewski JA; Bence-Bruckler I; To B; Geisler CH; Schots R; Kimby E; Taverna CJ; Kozák T; Dreger P; Uddin R; Ruiz de Elvira C; Goldstone AH
J Clin Oncol; 2013 May; 31(13):1624-30. PubMed ID: 23547078
[TBL] [Abstract][Full Text] [Related]
9. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study.
Askeland G
Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446
[No Abstract] [Full Text] [Related]
10. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R
Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
[TBL] [Abstract][Full Text] [Related]
11. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous xanthogranulomas, hepatosplenomegaly, anemia, and thrombocytopenia as presenting signs of juvenile myelomonocytic leukemia.
Cham E; Siegel D; Ruben BS
Am J Clin Dermatol; 2010; 11(1):67-71. PubMed ID: 20000879
[TBL] [Abstract][Full Text] [Related]
13. Rituximab maintenance therapy for follicular lymphoma: no better than watchful waiting.
Prescrire Int; 2012 Mar; 21(125):62. PubMed ID: 22428182
[TBL] [Abstract][Full Text] [Related]
14. Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.
Brunet-Possenti F; Franck N; Tamburini J; Jacobelli S; Avril MF; Dupin N
Dermatology; 2011; 223(3):200-2. PubMed ID: 21986026
[TBL] [Abstract][Full Text] [Related]
15. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
[No Abstract] [Full Text] [Related]
16. [A case of malignant lymphoma associated with diffuse pulmonary involvement successfully treated with rituximab].
Kataoka T; Ishida Y; Kurokawa R; Takeshita S; Ohta K; Nishimura Y; Yokoyama M
Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):899-904. PubMed ID: 14727553
[TBL] [Abstract][Full Text] [Related]
17. Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.
Villa D; Crump M; Panzarella T; Savage KJ; Toze CL; Stewart DA; MacDonald DA; Buckstein R; Lee C; Alzahrani M; Rubinger M; Foley R; Xenocostas A; Sabloff M; Muccilli A; Chua N; Couture F; Larouche JF; Cohen S; Connors JM; Ambler K; Al-Tourah A; Ramadan KM; Kuruvilla J
J Clin Oncol; 2013 Mar; 31(9):1164-71. PubMed ID: 23401459
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
[TBL] [Abstract][Full Text] [Related]
19. Maintenance therapy in follicular lymphoma.
Michallet AS; Coiffier B; Salles G
Curr Opin Oncol; 2011 Sep; 23(5):449-54. PubMed ID: 21734580
[TBL] [Abstract][Full Text] [Related]
20. Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.
Aoi J; Makino K; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Koga H; Hashimoto T; Ihn H
J Dermatol; 2013 Apr; 40(4):285-6. PubMed ID: 23398274
[No Abstract] [Full Text] [Related]
[Next] [New Search]
